Track Medtech Start-ups

Learn More
innovation hub

Second Sight Medical (NASDAQ:EYES) is Profiled in this Database

Updated At 18 Aug, 2018

Start Free 7 Day Trial Now
Partial description of this company
Retinal prosthesis system that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Second Sight Medical (NASDAQ:EYES) plus 4750 other startups.

Start Free 7 Day Trial Now

Learn More About Second Sight Medical (NASDAQ:EYES)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

More

Our Clients